- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.95 Å
- Oligo State
- monomer
- Ligands
- 1 x UQX: (3R)-2-[N-(1H-indazole-5-carbonyl)-3-methyl-D-phenylalanyl]-N-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxamide(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x SO4: SULFATE ION(Non-functional Binders)
- 1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Robbins, D.W. et al., Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton's Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell Malignancies. J.Med.Chem. (2024)
- Release Date
- 2024-01-31
- Peptides
- Tyrosine-protein kinase BTK: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A